Title: A cohort study to establish the prevalence of mutations in patients with CML who meet the ELN criteria for warning or failure and patients with Ph+ALL with detectable BCR-ABL1 currently being treated with first or subsequent TKI therapy in the UK

Funder
Cardiff & Vale University Health Board

Principal Investigator

Project Details
Net value award figure for Cardiff University: £6,526.00
Start date: 06/12/2019
End date: 30/06/2020

Last updated on 2020-18-09 at 06:01